Nanmo Biotech announced on January 5 that Shanghai Doshi Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, recently signed the “Shanghai Zhangjiang National Independent Innovation Demonstration Zone Special Development Fund Project Management Contract” and is expected to receive 5.8 million yuan in government subsidies, including 2.9 million yuan in asset-related government subsidies, accounting for 0.15% of the company's total audited assets in the most recent fiscal year; 2.9 million yuan in government subsidies related to revenue, accounting for 44.65% of the company's audited net profit in the most recent fiscal year. As of the disclosure date of this announcement, the above subsidy funds have not been received.

Nanmo Biotech announced on January 5 that Shanghai Doshi Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, recently signed the “Shanghai Zhangjiang National Independent Innovation Demonstration Zone Special Development Fund Project Management Contract” and is expected to receive 5.8 million yuan in government subsidies, including 2.9 million yuan in asset-related government subsidies, accounting for 0.15% of the company's total audited assets in the most recent fiscal year; 2.9 million yuan in government subsidies related to revenue, accounting for 44.65% of the company's audited net profit in the most recent fiscal year. As of the disclosure date of this announcement, the above subsidy funds have not been received.